Literature DB >> 22904161

Regulation of cardiac alternans by β-adrenergic signaling pathways.

Stela M Florea1, Lothar A Blatter.   

Abstract

In cat atrial myocytes, β-adrenergic receptor (β-AR) stimulation exerts profound effects on excitation-contraction coupling and cellular Ca(2+) cycling that are mediated by β(1)- and β(2)-AR subtypes coupled to G proteins (G(s) and G(i)). In this study, we determined the effects of β-AR stimulation on pacing-induced Ca(2+) alternans. Ca(2+) alternans was recorded from single cat atrial myocytes with the fluorescent Ca(2+) indicator indo-1. Stable Ca(2+) alternans occurred at an average pacing frequency of 1.7 Hz at room temperature with a mean alternans ratio of 0.43. Nonselective β-AR stimulation as well as selective stimulation of β(1)/G(s), β(2)/G(s) + G(i), and β(2)/G(s) coupled pathways all abolished pacing-induced Ca(2+) alternans. β(1)-AR stimulation abolished alternans through stimulation of PKA and Ca(2+)/calmodulin-dependent protein kinase II, whereas β(2)-AR stimulation exclusively involved PKA and was mediated via G(s), whereas a known second pathway in cat atrial myocytes acting through G(i) and nitric oxide production was not involved in alternans regulation. Inhibition of various mitochondrial functions (dissipation of the mitochondrial membrane potential or inhibition of mitochondrial F(1)/F(0)-ATP synthase, mitochondrial Ca(2+) uptake via the mitochondrial Ca(2+) uniporter, and Ca(2+) extrusion via mitochondrial Na(+)/Ca(2+) exchange) enhanced Ca(2+) alternans; however, β-AR stimulation still abrogated alternans, provided that sufficient cellular ATP was available. Selective inhibition of mitochondrial or glycolytic ATP production did not prevent β-AR stimulation from abolishing Ca(2+) alternans. However, when both ATP sources were depleted, β-AR stimulation failed to decrease Ca(2+) alternans. These results indicate that in atrial myocytes, β-AR stimulation protects against pacing-induced alternans by acting through parallel and complementary signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22904161      PMCID: PMC3469647          DOI: 10.1152/ajpheart.00384.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  63 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

Review 2.  From pulsus to pulseless: the saga of cardiac alternans.

Authors:  James N Weiss; Alain Karma; Yohannes Shiferaw; Peng-Sheng Chen; Alan Garfinkel; Zhilin Qu
Journal:  Circ Res       Date:  2006-05-26       Impact factor: 17.367

3.  Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.

Authors:  R P Xiao; X Ji; E G Lakatta
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

4.  Refractoriness of sarcoplasmic reticulum Ca2+ release determines Ca2+ alternans in atrial myocytes.

Authors:  Vyacheslav M Shkryl; Joshua T Maxwell; Timothy L Domeier; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-30       Impact factor: 4.733

5.  Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling.

Authors:  L Adam; M Bouvier; T L Jones
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

6.  Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death.

Authors:  Andriy E Belevych; Dmitry Terentyev; Serge Viatchenko-Karpinski; Radmila Terentyeva; Arun Sridhar; Yoshinori Nishijima; Lance D Wilson; Arturo J Cardounel; Kenneth R Laurita; Cynthia A Carnes; George E Billman; Sandor Gyorke
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

7.  Characteristics and function of cardiac mitochondrial nitric oxide synthase.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Physiol       Date:  2008-12-22       Impact factor: 5.182

Review 8.  The link between repolarisation alternans and ventricular arrhythmia: does the cellular phenomenon extend to the clinical problem?

Authors:  Rachel C Myles; Francis L Burton; Stuart M Cobbe; Godfrey L Smith
Journal:  J Mol Cell Cardiol       Date:  2008-04-09       Impact factor: 5.000

9.  Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.

Authors:  Klaus Pönicke; Ferdinand Gröner; Ingrid Heinroth-Hoffmann; Otto-Erich Brodde
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

10.  Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.

Authors:  R P Xiao; P Avdonin; Y Y Zhou; H Cheng; S A Akhter; T Eschenhagen; R J Lefkowitz; W J Koch; E G Lakatta
Journal:  Circ Res       Date:  1999 Jan 8-22       Impact factor: 17.367

View more
  17 in total

1.  Cardiac myocyte alternans in intact heart: Influence of cell-cell coupling and β-adrenergic stimulation.

Authors:  Karin P Hammer; Senka Ljubojevic; Crystal M Ripplinger; Burkert M Pieske; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2015-03-28       Impact factor: 5.000

2.  Ca2+/calmodulin-dependent kinase II-dependent regulation of atrial myocyte late Na+ current, Ca2+ cycling, and excitability: a mathematical modeling study.

Authors:  Birce Onal; Daniel Gratz; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

Review 3.  Cardiac alternans and intracellular calcium cycling.

Authors:  Joshua N Edwards; Lothar A Blatter
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-07       Impact factor: 2.557

4.  β-Adrenergic signaling, monoamine oxidase A and antioxidant defence in the myocardium of SHR and SHR-mtBN conplastic rat strains: the effect of chronic hypoxia.

Authors:  Klara Hahnova; Iveta Brabcova; Jan Neckar; Romana Weissova; Anna Svatonova; Olga Novakova; Jitka Zurmanova; Martin Kalous; Jan Silhavy; Michal Pravenec; Frantisek Kolar; Jiri Novotny
Journal:  J Physiol Sci       Date:  2017-05-31       Impact factor: 2.781

5.  Effects of mitochondrial uncoupling on Ca(2+) signaling during excitation-contraction coupling in atrial myocytes.

Authors:  Aleksey V Zima; Malikarjuna R Pabbidi; Stephen L Lipsius; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-01       Impact factor: 4.733

6.  The mechanisms of calcium cycling and action potential dynamics in cardiac alternans.

Authors:  Giedrius Kanaporis; Lothar A Blatter
Journal:  Circ Res       Date:  2014-12-22       Impact factor: 17.367

7.  (-)-Epigallocatechin-3-gallate, the major green tea catechin, regulates the desensitization of β1 adrenoceptor via GRK2 in experimental heart failure.

Authors:  Qi Zhang; Liqun Hu; Li Chen; Hongqi Li; Jun Wu; Wenting Liu; Mengyuan Zhang; Guang Yan
Journal:  Inflammopharmacology       Date:  2017-12-16       Impact factor: 4.473

8.  Mitochondrial dysfunction, alternans, and arrhythmias.

Authors:  Miguel A Aon
Journal:  Front Physiol       Date:  2013-04-19       Impact factor: 4.566

9.  Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation.

Authors:  Sarah Kettlewell; Francis L Burton; Godfrey L Smith; Antony J Workman
Journal:  Cardiovasc Res       Date:  2013-04-08       Impact factor: 10.787

10.  Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation.

Authors:  Funsho E Fakuade; Vanessa Steckmeister; Fitzwilliam Seibertz; Judith Gronwald; Stefanie Kestel; Julia Menzel; Julius Ryan D Pronto; Karim Taha; Fereshteh Haghighi; George Kensah; Charles M Pearman; Felix Wiedmann; Arco J Teske; Constanze Schmidt; Katharine M Dibb; Aschraf El-Essawi; Bernhard C Danner; Hassina Baraki; Blanche Schwappach; Ingo Kutschka; Fleur E Mason; Niels Voigt
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.